Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Quantifying unobserved protein-coding variants in human populations provides a roadmap for large-scale sequencing projects

Quantifying unobserved protein-coding variants in human populations provides a roadmap for large-scale sequencing projects

Thumbnail Image
Download
Name

Quantifying unobserved.pdf

Size

227.76 KB

Format

Adobe PDF

Checksum (MD5)

d495813975cd772ed734dd216a356a41

Author(s)
Zou, James
•
Valiant, Gregory
•
Valiant, Paul
•
Karczewski, Konrad
•
Chan, Siu On
•
Samocha, Kaitlin
•
Lek, Monkol
•
MacArthur, Daniel G.
•
Sunyaev, Shamil R.
•
Daly, Mark J.
Date Issued
October 2016
Journal
Nature Communications
Publisher
Nature Publishing Group
Citation
Zou, James; Valiant, Gregory; Valiant, Paul; Karczewski, Konrad; Chan, Siu On; Samocha, Kaitlin; Lek, Monkol; Sunyaev, Shamil; Daly, Mark and MacArthur, Daniel G. “Quantifying Unobserved Protein-Coding Variants in Human Populations Provides a Roadmap for Large-Scale Sequencing Projects.” Nature Communications 7 (October 2016): 13293. © 2017 Macmillan Publishers Limited, part of Springer Nature
Version
Final published version
Abstract
As new proposals aim to sequence ever larger collection of humans, it is critical to have a quantitative framework to evaluate the statistical power of these projects. We developed a new algorithm, UnseenEst, and applied it to the exomes of 60,706 individuals to estimate the frequency distribution of all protein-coding variants, including rare variants that have not been observed yet in the current cohorts. Our results quantified the number of new variants that we expect to identify as sequencing cohorts reach hundreds of thousands of individuals. With 500K individuals, we find that we expect to capture 7.5% of all possible loss-of-function variants and 12% of all possible missense variants. We also estimate that 2,900 genes have loss-of-function frequency of <0.00001 in healthy humans, consistent with very strong intolerance to gene inactivation.
MIT Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Broad Institute of MIT and Harvard
Harvard University--MIT Division of Health Sciences and Technology
Terms of Use
Creative Commons Attribution 4.0 International License
http://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/109155
DOI of Published Version
https://doi.org/10.1038/ncomms13293
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.